Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2003
03/13/2003US20030049643 G protein-coupled receptors for use in the treatment of cardiovascular, nervous system, angina pectoris, inflamatory bowel, allergies and gastrointestinal disorders
03/13/2003US20030049617 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
03/13/2003US20030049609 Viral proteins capable of binding LAR
03/13/2003US20030049604 Viral proteins for use in the treatment and prevention of infection and viral diseases
03/13/2003US20030049322 Aqueous-based pharmaceutical composition
03/13/2003US20030049280 Spontaneous emulsions containing cyclosporine
03/13/2003US20030049279 Polysaccharide encapsualted antigen
03/13/2003US20030049267 Systemic immune response induced by mucosal administration of lipid-tailed polypeptides without adjuvant
03/13/2003US20030049266 Induce immunology response usin gpolynucleotide
03/13/2003US20030049261 Administering chitinase inhibitor
03/13/2003US20030049252 Controlling immunology response; autoimmune disease, antiallergens
03/13/2003US20030049229 Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
03/13/2003CA2471735A1 Desensitizers
03/13/2003CA2459796A1 Homing peptides
03/13/2003CA2459348A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003CA2459136A1 A caspase-8 binding protein, its preparation and use
03/13/2003CA2458995A1 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
03/13/2003CA2458985A1 Antibodies against caspase-8, their preparation and use
03/13/2003CA2458876A1 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
03/13/2003CA2458682A1 Nanoparticles comprising biologically active tnf which is immobilised on the same
03/13/2003CA2458678A1 Agent for treating or preventing allergic disease comprising treated product of peanut seed coats
03/13/2003CA2458399A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
03/13/2003CA2457926A1 Pharmaceutical compositions for the treatment of asthma
03/13/2003CA2457861A1 Piperidine derivatives useful as ccr5 antagonists
03/13/2003CA2456904A1 Aerosolized decongestants for the treatment of sinusitis
03/13/2003CA2422135A1 Urea derivatives and adhesion molecule inhibitors containing the same as effective ingredients
03/12/2003EP1291423A1 Polyfunctional base sequence and artificial gene containing the same
03/12/2003EP1291360A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
03/12/2003EP1291346A1 Process for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties
03/12/2003EP1291345A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
03/12/2003EP1291020A2 Use of cytokines and mitogens to inhibit pathological immune responses
03/12/2003EP1291015A1 Dosage forms having prolonged active ingredient release
03/12/2003EP1291013A2 Storage-stable pharmaceutical compositions
03/12/2003EP1290939A1 Caspase 1 gene transfer animal
03/12/2003EP1290193A2 Protein phosphatases
03/12/2003EP1290187A2 Humain kinases
03/12/2003EP1290180A2 Drug metabolizing enzymes
03/12/2003EP1290170A2 Binding agents: chimeric ligand/receptor proteins
03/12/2003EP1290161A1 METHODS FOR MEDIATING GENE SUPPRESION BY USING FACTORS THAT ENHANCE RNAi
03/12/2003EP1290154A2 The identification and use of effectors and allosteric molecules for the alteration of gene expression
03/12/2003EP1290148A2 AMINOACYL tRNA SYNTHETASES
03/12/2003EP1290140A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof
03/12/2003EP1290136A1 Novel probiotics for pet food applications
03/12/2003EP1290023A2 Nuclear factor kb inducing factor
03/12/2003EP1289997A1 Macrolides
03/12/2003EP1289993A1 Caspase inhibitors and uses thereof
03/12/2003EP1289990A1 Tetracyclic diketopierazine compounds as pdev inhibitors
03/12/2003EP1289989A2 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
03/12/2003EP1289980A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
03/12/2003EP1289968A1 Cyclic urea compounds and preparation thereof
03/12/2003EP1289961A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
03/12/2003EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a)
03/12/2003EP1289957A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
03/12/2003EP1289956A1 Chemical compounds
03/12/2003EP1289955A1 Piperidines for use as orexin receptor antagonists
03/12/2003EP1289951A1 Growth hormone secretagogues
03/12/2003EP1289945A1 Aniline disulfide derivatives for treating allergic diseases
03/12/2003EP1289944A2 Thioketals and thioethers for inhibiting the expression of vcam-1
03/12/2003EP1289564A2 T cell receptor fusions and conjugates and methods of use thereof
03/12/2003EP1289559A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
03/12/2003EP1289555A2 Method to induce the th1 immune response
03/12/2003EP1289551A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
03/12/2003EP1289550A1 Chlamydial glycolipid vaccines
03/12/2003EP1289549A2 The use of plant oil-bodies in vaccine delivery systems
03/12/2003EP1289548A2 Immune system stimulating means
03/12/2003EP1289545A1 Snthetic vaccine for tick control
03/12/2003EP1289541A2 Interferon for the treatment of multiple sclerosis
03/12/2003EP1289539A1 Pharmaceutical anti-inflammatory aerosol formulation
03/12/2003EP1289536A2 Apoptotic entities for use in treatment of endothelium dysfunction disorders
03/12/2003EP1289535A2 Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
03/12/2003EP1289534A2 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
03/12/2003EP1289530A1 Lipids for modulating immune response
03/12/2003EP1289525A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
03/12/2003EP1289501A1 Novel aqueous anti-inflammatory pharmaceutical formulation
03/12/2003EP1036058B1 Adamantane derivatives
03/12/2003EP0881886B1 Animal feed
03/12/2003EP0845984B1 Use of aminoadamantane compounds as immunoregulators
03/12/2003EP0787016B1 Secretory leukocyte protease inhibitor (slpi) as an inhibitor of tryptase
03/12/2003EP0763039B1 42-rapamycin hydroxyester, process for its preparation and pharmaceutical compositions containing it
03/12/2003EP0758243B1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWISa
03/12/2003EP0729459B1 Phenyl-alkyl imidazoles as h3-receptor antagonists
03/12/2003EP0705339B1 Human cell adhesion protein aamp-1 and uses thereof
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/12/2003CN1402734A 3-methylene steroid deriv.
03/12/2003CN1402733A Angiogenic proteins and uses thereof
03/12/2003CN1402730A Thiazolo (4,5-D) pyrimidine compounds
03/12/2003CN1402728A Method for producing epinastine hydrochloride in high-melting crystal modification
03/12/2003CN1402721A Benzoimidazole derivs. useful as antiproliferative agents
03/12/2003CN1402720A 2,4-diaminopyrimidine compounds useful as immunosuppressants
03/12/2003CN1402640A Stabilized liquid polypeptide-confg. pharmaceutical compositions
03/12/2003CN1401653A Scrophularia oligose, production method and use thereof
03/12/2003CN1401390A Immunoregulation medicine-antibody poietins, preparing process and use thereof
03/12/2003CN1401365A Chinese health medicine
03/12/2003CN1102931C Acylated N-hydroxy methyl thalidomide prodrugs with immunomodulator action
03/11/2003US6531612 Nitrile derivatives that inhibit cathepsin K
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531600 Treatment and compounds
03/11/2003US6531505 Flavanoids or chromones of given formula that inhibit activated T cells; used for treating autoimmune disease, inflammatory reaction, fibrosis, transplant rejection, graft versus host disease, or allergic disease
03/11/2003US6531498 Antiallergens, etc
03/11/2003US6531492 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
1 ... 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 ... 1172